z-logo
Premium
Treatment of idiopathic onychodystrophy with a 1064 nm picosecond neodymium‐doped:yttrium aluminum garnet laser: A retrospective study
Author(s) -
Lee Yun Ho,
Lee Heun Joo,
Kim WonSerk,
Lee GaYoung,
Choi YoungJun
Publication year - 2021
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.13580
Subject(s) - medicine , adverse effect , neodymium , dermatology , laser , lesion , surgery , optics , physics
Background Laser treatment has emerged as a novel treatment modality for onychodystrophy. Only a few small series have assessed the efficacy of laser treatment in onychodystrophy, most of which were case reports. The therapeutic effect of the 1064 nm neodymium‐doped:yttrium aluminum garnet (Nd:YAG) laser for onychodystrophy has been demonstrated. Recently, the picosecond Nd:YAG (PSNY) laser has been introduced to improve various skin disorders. Aims The aim of this study was to verify the efficacy of a 1064 nm PSNY in management of idiopathic onychodystrophy. Methods We present a case series of dystrophic nails treated with a PSNY for onychodystrophy improvement. Planimetry using ImageJ software was used to calculate lesion reduction and proximal clear nail growth. Clinical improvement was assessed using a 5‐point Global Assessment Scale (GAS). Adverse events were also assessed. Results Twenty‐five patients (11 males and 14 females) with a total of 128 nails (94 finger nails and 34 toe nails) were treated. The mean treatment number was 8.7 ± 6.2, and the mean total duration of treatment was 33.4 ± 34.6 weeks. The average proportion of the lesion area decreased significantly (from 65.9% to 46.6%) after PSNY treatment ( P  < .001). The mean GAS (3.16 ± 1.18) exhibited fair improvement, and there were no serious adverse events. Conclusion The 1064 nm PSNY laser can provide fair improvement for onychodystrophy with a good prognosis at least during the follow‐up period and optimal cosmetic results in Asian patients.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here